ReviewBBA clinical2016

The broken "Off" switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance.

Peter P RuvoloPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.